WGS
GeneDx Holdings Corp.
Price Chart
Latest Quote
$56.27
+3.25 (+6.13%)
Current Price
| Previous Close | $53.02 |
| Open | $54.00 |
| Day High | $57.15 |
| Day Low | $52.73 |
| Volume | 1,529,125 |
Stock Information
| Shares Outstanding | 29.69M |
| Total Debt | $168.19M |
| Cash Equivalents | $170.68M |
| Revenue | $442.68M |
| Net Income | $-77.81M |
| Sector | Healthcare |
| Industry | Diagnostics & Research |
| Market Cap | $1.55B |
| EPS (TTM) | $-2.66 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $1.55B |
| Sales | $442.68M |
| Income | $-77.81M |
| Book/sh | $10.54 |
| Cash/sh | $5.75 |
| Employees | 1K |
Financial Ratios
| Quick Ratio | 2.83 |
| Current Ratio | 3.09 |
| Debt/Eq | 66.19 |
Returns & Margins
| ROA | -4.37% |
| ROE | -30.42% |
| Gross Margin | 69.56% |
| Operating Margin | -25.61% |
| Profit Margin | -17.58% |
Ownership
| Insider Ownership | 12.12% |
| Institutional Ownership | 112.80% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | 42.40 |
| P/S | 3.50 |
| P/B | 4.95 |
Analyst Data
| Recommendation | strong_buy |
| Target Price | $77.00 |
Technical Indicators
| SMA20 | $46.45 |
| SMA50 | $55.84 |
| SMA200 | $102.49 |
| RSI | 74.47 |
| ATR | 3.6950 |
| Shares Float | 18.81M |
| Short Float | 31.93% |
| Short Ratio | 2.86 |
| Volatility | 1.97 |
| Rel Volume | 0.85 |
Performance History
| Week | +0.42% |
| Month | +50.42% |
| Quarter | -40.74% |
| 6 Months | -67.45% |
| YTD | -60.54% |
| Year | -27.88% |
| 3 Years | +594.28% |
| 5 Years | -87.50% |
| 10 Years | -83.86% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-05 | $52.21 | 1,180,700 |
| 2026-06-04 | $56.27 | 1,631,000 |
| 2026-06-03 | $53.02 | 1,082,700 |
| 2026-06-02 | $53.13 | 1,046,900 |
| 2026-06-01 | $52.00 | 1,156,200 |
| 2026-05-29 | $51.99 | 1,141,300 |
| 2026-05-28 | $50.15 | 1,304,000 |
| 2026-05-27 | $48.21 | 1,165,700 |
| 2026-05-26 | $49.44 | 911,300 |
| 2026-05-22 | $47.31 | 1,087,600 |
| 2026-05-21 | $47.33 | 2,280,600 |
| 2026-05-20 | $44.73 | 1,144,000 |
| 2026-05-19 | $42.13 | 1,655,600 |
| 2026-05-18 | $42.69 | 1,513,200 |
| 2026-05-15 | $40.75 | 1,630,300 |
| 2026-05-14 | $38.85 | 1,481,700 |
| 2026-05-13 | $38.94 | 1,153,700 |
| 2026-05-12 | $39.49 | 1,386,700 |
| 2026-05-11 | $39.61 | 1,817,600 |
| 2026-05-08 | $40.77 | 2,106,100 |
| 2026-05-07 | $40.50 | 4,236,500 |
| 2026-05-06 | $34.71 | 4,268,300 |
About GeneDx Holdings Corp.
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services. It also develops an AI-based platform for next generation sequencing analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing. GeneDx Holdings Corp. was founded in 2000 and is headquartered in Stamford, Connecticut.
đ° Latest News
GeneDx Holdings (WGS) Valuation After Q1 2026 Earnings Miss Guidance Cut And Legal Scrutiny
Simply Wall St. âĸ 2026-06-06T13:19:07Z
This Healthcare Investor Added $43 Million to a Genomics Leader Growing Volume 34%
Motley Fool âĸ 2026-05-23T20:37:22Z
Ashland, GeneDX Holdings, and 3 More Stocks See Action From Activist Investors
Barrons.com âĸ 2026-05-22T22:23:00Z
Is GeneDx Stock a Buys After a Company Director Purchased Over 350,000 Shares?
Motley Fool âĸ 2026-05-21T14:43:01Z
Prenetics Starts Partnership with Jay Shetty as IM8 Global Ambassador & Shareholder
IPO-Edge.com âĸ 2026-05-20T20:51:00Z
A Look At GeneDx Holdings (WGS) Valuation After Earnings Miss Guidance Cut And Securities Investigation
Simply Wall St. âĸ 2026-05-16T15:12:06Z
GeneDx (WGS) Fell Despite Continued Execution Improvement
Insider Monkey âĸ 2026-05-14T13:13:58Z
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Motley Fool âĸ 2026-05-06T14:32:00Z
The 'Alarming' Results That Caused GeneDx Stock To Plummet 49%
Investor's Business Daily âĸ 2026-05-05T20:30:27Z
Why GeneDX Stock Is Plummeting Today
Motley Fool âĸ 2026-05-05T15:23:48Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $129,366,000 | $111,053,000 | $112,560,000 | $261,444,000 |
| Cost Of Revenue | $129,366,000 | $111,053,000 | $112,560,000 | $261,444,000 |
| Total Revenue | $427,539,000 | $305,450,000 | $202,566,000 | $234,694,000 |
| Operating Revenue | $416,668,000 | $302,157,000 | $195,654,000 | $227,334,000 |
| Expenses | ||||
| Total Expenses | $440,616,000 | $328,663,000 | $372,760,000 | $692,201,000 |
| Other Income Expense | $-5,521,000 | $-26,384,000 | $-7,613,000 | $-139,859,000 |
| Other Non Operating Income Expenses | $-4,317,000 | $-13,014,000 | $1,619,000 | $57,000 |
| Net Non Operating Interest Income Expense | $-2,539,000 | $-3,032,000 | $1,114,000 | $-666,000 |
| Total Other Finance Cost | $2,539,000 | $3,032,000 | $-1,114,000 | $666,000 |
| Operating Expense | $311,250,000 | $217,610,000 | $260,200,000 | $430,757,000 |
| Selling And Marketing Expense | $88,405,000 | $67,371,000 | $60,956,000 | $122,075,000 |
| General And Administrative Expense | $150,819,000 | $104,517,000 | $139,021,000 | $216,167,000 |
| Other Operating Expenses | - | $3,407,000 | $1,957,000 | $6,312,000 |
| Interest Expense | - | - | - | $3,207,000 |
| Interest Expense Non Operating | - | - | - | $3,207,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Net Interest Income | $-2,539,000 | $-3,032,000 | $1,114,000 | $-666,000 |
| Normalized Income | $-19,823,020 | $-39,003,137 | $-166,583,382 | $-420,537,112 |
| Net Income From Continuing And Discontinued Operation | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Total Operating Income As Reported | $-13,077,000 | $-23,213,000 | $-180,596,000 | $-667,652,000 |
| Net Income Common Stockholders | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Net Income | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Net Income Including Noncontrolling Interests | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Net Income Continuous Operations | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Pretax Income | $-21,137,000 | $-52,629,000 | $-176,693,000 | $-598,032,000 |
| Special Income Charges | $0 | $0 | $-10,402,000 | $-210,145,000 |
| Operating Income | $-13,077,000 | $-23,213,000 | $-170,194,000 | $-457,507,000 |
| Gross Profit | $298,173,000 | $194,397,000 | $90,006,000 | $-26,750,000 |
| Interest Income | - | - | - | $2,541,000 |
| Interest Income Non Operating | - | - | - | $2,541,000 |
| Per Share | ||||
| Diluted EPS | - | $-1.94 | $-7.23 | $-53.79 |
| Basic EPS | - | $-1.94 | $-7.23 | $-53.79 |
| Other | ||||
| Tax Effect Of Unusual Items | $-6,020 | $-87,137 | $-48,382 | $-11,473,112 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $13,351,000 | $12,110,000 | $-127,228,000 | $-258,282,000 |
| Total Unusual Items | $-1,204,000 | $-13,370,000 | $-9,232,000 | $-139,916,000 |
| Total Unusual Items Excluding Goodwill | $-1,204,000 | $-13,370,000 | $-9,232,000 | $-139,916,000 |
| Reconciled Depreciation | $25,224,000 | $21,953,000 | $33,734,000 | $59,309,000 |
| EBITDA (Bullshit earnings) | $12,147,000 | $-1,260,000 | $-136,460,000 | $-398,198,000 |
| EBIT | $-13,077,000 | $-23,213,000 | $-170,194,000 | $-457,507,000 |
| Diluted NI Availto Com Stockholders | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Tax Provision | $-116,000 | $-343,000 | $-926,000 | $-49,052,000 |
| Write Off | $0 | $0 | $10,402,000 | $210,145,000 |
| Gain On Sale Of Security | $-1,204,000 | $-13,370,000 | $1,170,000 | $70,229,000 |
| Research And Development | $72,026,000 | $45,722,000 | $58,266,000 | $86,203,000 |
| Selling General And Administration | $239,224,000 | $171,888,000 | $199,977,000 | $338,242,000 |
| Other Gand A | $150,819,000 | $104,517,000 | $139,021,000 | $216,167,000 |
| Diluted Average Shares | - | $26,891,213 | $24,311,989 | $10,236,959 |
| Basic Average Shares | - | $26,891,213 | $24,311,989 | $10,236,959 |
Fetched: 2026-05-25
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $126,181,000 | $86,647,000 | $55,392,000 | $67,055,000 |
| Total Assets | $523,710,000 | $419,380,000 | $418,756,000 | $490,942,000 |
| Total Non Current Assets | $255,422,000 | $221,412,000 | $236,417,000 | $278,320,000 |
| Other Non Current Assets | $4,316,000 | $4,306,000 | $4,413,000 | $7,385,000 |
| Goodwill And Other Intangible Assets | $182,001,000 | $158,600,000 | $172,625,000 | $186,650,000 |
| Other Intangible Assets | $168,481,000 | $158,600,000 | $172,625,000 | $186,650,000 |
| Current Assets | $268,288,000 | $197,968,000 | $182,339,000 | $212,622,000 |
| Other Current Assets | $1,511,000 | $1,079,000 | $1,958,000 | $31,682,000 |
| Prepaid Assets | $7,174,000 | $7,425,000 | $8,640,000 | $11,822,000 |
| Inventory | $13,951,000 | $10,650,000 | $8,777,000 | $13,665,000 |
| Receivables | $74,370,000 | $37,629,000 | $32,816,000 | $43,342,000 |
| Accounts Receivable | $74,370,000 | $37,629,000 | $32,371,000 | $42,634,000 |
| Cash Cash Equivalents And Short Term Investments | $171,282,000 | $141,185,000 | $130,148,000 | $123,933,000 |
| Cash And Cash Equivalents | $104,997,000 | $85,212,000 | $99,681,000 | $123,933,000 |
| Restricted Cash | - | - | - | $13,470,000 |
| Debt | ||||
| Total Debt | $113,168,000 | $117,379,000 | $119,273,000 | $77,134,000 |
| Long Term Debt And Capital Lease Obligation | $104,222,000 | $112,832,000 | $115,626,000 | $66,263,000 |
| Long Term Debt | $48,176,000 | $51,913,000 | $52,688,000 | $6,250,000 |
| Current Debt And Capital Lease Obligation | $8,946,000 | $4,547,000 | $3,647,000 | $10,871,000 |
| Current Debt | $4,542,000 | $1,211,000 | $497,000 | $4,750,000 |
| Other Current Borrowings | $4,542,000 | $1,211,000 | $497,000 | $4,750,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $215,528,000 | $174,133,000 | $190,739,000 | $237,237,000 |
| Total Non Current Liabilities Net Minority Interest | $106,620,000 | $119,316,000 | $131,921,000 | $92,940,000 |
| Other Non Current Liabilities | $1,641,000 | - | - | $1,600,000 |
| Derivative Product Liabilities | $0 | $3,519,000 | $2,735,000 | $418,000 |
| Non Current Deferred Liabilities | $757,000 | $965,000 | $1,560,000 | $2,659,000 |
| Non Current Deferred Taxes Liabilities | $757,000 | $965,000 | $1,560,000 | $2,659,000 |
| Current Liabilities | $108,908,000 | $54,817,000 | $58,818,000 | $144,297,000 |
| Other Current Liabilities | $11,265,000 | $1,632,000 | $2,018,000 | $24,666,000 |
| Payables And Accrued Expenses | $47,763,000 | $21,065,000 | $23,796,000 | $78,560,000 |
| Payables | $3,104,000 | $8,622,000 | $11,617,000 | $49,610,000 |
| Accounts Payable | $2,461,000 | $7,954,000 | $10,238,000 | $46,017,000 |
| Current Deferred Liabilities | - | - | - | $40,000 |
| Equity | ||||
| Common Stock Equity | $308,182,000 | $245,247,000 | $228,017,000 | $253,705,000 |
| Total Equity Gross Minority Interest | $308,182,000 | $245,247,000 | $228,017,000 | $253,705,000 |
| Stockholders Equity | $308,182,000 | $245,247,000 | $228,017,000 | $253,705,000 |
| Gains Losses Not Affecting Retained Earnings | $936,000 | $830,000 | $425,000 | $0 |
| Other Equity Adjustments | $936,000 | $830,000 | $425,000 | - |
| Retained Earnings | $-1,373,495,000 | $-1,352,474,000 | $-1,300,188,000 | $-1,124,421,000 |
| Preferred Securities Outside Stock Equity | - | - | - | - |
| Other | ||||
| Ordinary Shares Number | $29,245,296 | $28,016,545 | $25,978,863 | $11,773,064 |
| Share Issued | $29,245,296 | $28,016,545 | $25,978,863 | $11,773,064 |
| Tangible Book Value | $126,181,000 | $86,647,000 | $55,392,000 | $67,055,000 |
| Invested Capital | $360,900,000 | $298,371,000 | $280,705,000 | $264,705,000 |
| Working Capital | $159,380,000 | $143,151,000 | $123,521,000 | $68,325,000 |
| Capital Lease Obligations | $60,450,000 | $64,255,000 | $66,585,000 | $66,134,000 |
| Total Capitalization | $356,358,000 | $297,160,000 | $280,705,000 | $259,955,000 |
| Additional Paid In Capital | $1,680,738,000 | $1,596,889,000 | $1,527,778,000 | $1,378,125,000 |
| Capital Stock | $3,000 | $2,000 | $2,000 | $1,000 |
| Common Stock | $3,000 | $2,000 | $2,000 | $1,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Long Term Capital Lease Obligation | $56,046,000 | $60,919,000 | $62,938,000 | $60,013,000 |
| Current Capital Lease Obligation | $4,404,000 | $3,336,000 | $3,647,000 | $6,121,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $30,409,000 | $16,987,000 | $14,318,000 | $13,199,000 |
| Current Provisions | $10,525,000 | $10,586,000 | $15,039,000 | $17,001,000 |
| Current Accrued Expenses | $44,659,000 | $12,443,000 | $12,179,000 | $28,950,000 |
| Dueto Related Parties Current | $643,000 | $668,000 | $1,379,000 | $3,593,000 |
| Goodwill | $13,520,000 | $0 | - | - |
| Net PPE | $69,105,000 | $58,506,000 | $59,379,000 | $84,285,000 |
| Accumulated Depreciation | $-25,517,000 | $-20,307,000 | $-46,452,000 | $-101,460,000 |
| Gross PPE | $94,622,000 | $78,813,000 | $105,831,000 | $185,745,000 |
| Leases | $14,802,000 | $14,655,000 | $14,614,000 | $35,561,000 |
| Construction In Progress | $7,447,000 | $4,960,000 | $3,106,000 | $3,386,000 |
| Other Properties | $56,298,000 | $47,173,000 | $45,042,000 | $95,397,000 |
| Machinery Furniture Equipment | $11,546,000 | $7,496,000 | $38,540,000 | $45,125,000 |
| Buildings And Improvements | $4,529,000 | $4,529,000 | $4,529,000 | $6,276,000 |
| Properties | $0 | $0 | $0 | $0 |
| Other Short Term Investments | $66,285,000 | $55,973,000 | $30,467,000 | $0 |
| Long Term Provisions | - | $2,000,000 | $12,000,000 | $22,000,000 |
| Duefrom Related Parties Current | - | $203,000 | $445,000 | $708,000 |
| Current Deferred Revenue | - | - | - | $40,000 |
| Employee Benefits | - | - | - | - |
Fetched: 2026-05-25
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $14,262,000 | $-33,987,000 | $-185,858,000 | $-333,477,000 |
| Operating Activities | ||||
| Operating Cash Flow | $33,279,000 | $-28,496,000 | $-180,147,000 | $-319,155,000 |
| Cash Flow From Continuing Operating Activities | $33,279,000 | $-28,496,000 | $-180,147,000 | $-319,155,000 |
| Operating Gains Losses | - | $13,370,000 | $-5,597,000 | $-70,229,000 |
| Investing Activities | ||||
| Capital Expenditure | $-19,017,000 | $-5,491,000 | $-5,711,000 | $-14,322,000 |
| Investing Cash Flow | $-61,517,000 | $-30,132,000 | $-43,726,000 | $-141,326,000 |
| Cash Flow From Continuing Investing Activities | $-61,517,000 | $-30,132,000 | $-43,726,000 | $-141,326,000 |
| Net Other Investing Changes | - | - | $-8,110,000 | - |
| Financing Activities | ||||
| Issuance Of Capital Stock | $46,704,000 | $46,496,000 | $143,002,000 | $197,659,000 |
| Financing Cash Flow | $48,025,000 | $44,162,000 | $186,238,000 | $197,315,000 |
| Cash Flow From Continuing Financing Activities | $48,025,000 | $44,162,000 | $186,238,000 | $197,315,000 |
| Net Common Stock Issuance | $46,704,000 | $46,496,000 | $143,002,000 | $197,659,000 |
| Common Stock Issuance | $46,704,000 | $46,496,000 | $143,002,000 | $197,659,000 |
| Net Other Financing Charges | - | - | - | $197,659,000 |
| Net Preferred Stock Issuance | - | - | - | $0 |
| Preferred Stock Issuance | - | - | - | $0 |
| Other | ||||
| Repayment Of Debt | $-3,662,000 | $-3,225,000 | $-5,598,000 | $-3,292,000 |
| Issuance Of Debt | $0 | $0 | $48,549,000 | $0 |
| Interest Paid Supplemental Data | $6,413,000 | $6,677,000 | $3,041,000 | $1,932,000 |
| Income Tax Paid Supplemental Data | $1,275,000 | $1,167,000 | $1,465,000 | $1,241,000 |
| End Cash Position | $105,989,000 | $86,202,000 | $100,668,000 | $138,303,000 |
| Beginning Cash Position | $86,202,000 | $100,668,000 | $138,303,000 | $401,469,000 |
| Changes In Cash | $19,787,000 | $-14,466,000 | $-37,635,000 | $-263,166,000 |
| Proceeds From Stock Option Exercised | $4,983,000 | $891,000 | $285,000 | $2,948,000 |
| Net Issuance Payments Of Debt | $-3,662,000 | $-3,225,000 | $42,951,000 | $-3,292,000 |
| Net Long Term Debt Issuance | $-3,662,000 | $-3,225,000 | $42,951,000 | $-3,292,000 |
| Long Term Debt Payments | $-3,662,000 | $-3,225,000 | $-5,598,000 | $-3,292,000 |
| Long Term Debt Issuance | $0 | $0 | $48,549,000 | $0 |
| Net Investment Purchase And Sale | $-9,644,000 | $-24,641,000 | $-29,905,000 | $0 |
| Sale Of Investment | $46,032,000 | $41,661,000 | $17,765,000 | $0 |
| Purchase Of Investment | $-55,676,000 | $-66,302,000 | $-47,670,000 | $0 |
| Net Business Purchase And Sale | $-32,856,000 | $0 | $0 | $-127,004,000 |
| Purchase Of Business | $-32,856,000 | $0 | $0 | $-127,004,000 |
| Net Intangibles Purchase And Sale | $0 | $0 | $-461,000 | $-7,166,000 |
| Purchase Of Intangibles | $0 | $0 | $-461,000 | $-7,166,000 |
| Net PPE Purchase And Sale | $-19,017,000 | $-5,491,000 | $-5,250,000 | $-7,156,000 |
| Purchase Of PPE | $-19,017,000 | $-5,491,000 | $-5,250,000 | $-7,156,000 |
| Change In Working Capital | $-15,597,000 | $-24,745,000 | $-38,241,000 | $33,881,000 |
| Change In Other Working Capital | $11,970,000 | $3,544,000 | $-575,000 | $-8,455,000 |
| Change In Payables And Accrued Expense | $12,100,000 | $-20,524,000 | $-49,167,000 | $34,459,000 |
| Change In Inventory | $-3,436,000 | $-2,585,000 | $975,000 | $2,350,000 |
| Change In Receivables | $-36,231,000 | $-5,180,000 | $10,526,000 | $5,527,000 |
| Changes In Account Receivables | $-36,231,000 | $-5,180,000 | $10,526,000 | $5,527,000 |
| Other Non Cash Items | $12,376,000 | $17,264,000 | $-13,862,000 | $2,743,000 |
| Stock Based Compensation | $32,162,000 | $9,138,000 | $-326,000 | $41,975,000 |
| Provisionand Write Offof Assets | $135,000 | $180,000 | $3,913,000 | $1,125,000 |
| Asset Impairment Charge | $0 | $0 | $10,402,000 | $210,145,000 |
| Depreciation Amortization Depletion | $25,224,000 | $21,953,000 | $33,734,000 | $59,309,000 |
| Depreciation And Amortization | $25,224,000 | $21,953,000 | $33,734,000 | $59,309,000 |
| Net Income From Continuing Operations | $-21,021,000 | $-52,286,000 | $-175,767,000 | $-548,980,000 |
| Deferred Tax | - | $-343,000 | $-926,000 | $-49,124,000 |
| Deferred Income Tax | - | $-343,000 | $-926,000 | $-49,124,000 |
| Gain Loss On Investment Securities | - | $13,370,000 | $-1,170,000 | $-70,229,000 |
| Change In Other Current Liabilities | - | - | - | $-19,467,000 |
| Change In Other Current Assets | - | - | - | $-2,000 |
| Change In Prepaid Assets | - | - | - | $11,130,000 |
Fetched: 2026-05-25